AIEC pathobiont instigates chronic colitis in susceptible hosts by altering microbiota composition

Gut

Volumn 63, Issue 7, 2014, Pages 1069-1080

  Chassaing, Benoit ^a   Koren, Omry ^b   Carvalho, Frederic A ^c   Ley, Ruth E ^b   Gewirtz, Andrew T ^a  

^a GEORGIA STATE UNIVERSITY   (United States)

^b Department of Obstetrics Gynecology   (United States)

^c Department of Pharmacology Inserm U1107 NEURO DOL Université d'Auvergne ^*  (France)

Author keywords

[No Author keywords available]

Indexed keywords

ESCHERICHIA COLI LIPOPOLYSACCHARIDE; FLAGELLIN; NEUTROPHIL GELATINASE ASSOCIATED LIPOCALIN;

ADHERENT INVASIVE ESCHERICHIA COLI; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BACTERIAL CLEARANCE; BACTERIAL COLONIZATION; BACTERIAL LOAD; BACTERIAL STRAIN; CHRONIC INFLAMMATION; COLITIS; CONTROLLED STUDY; EMBRYO; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTION; FECES ANALYSIS; HUMAN; HUMAN CELL; INNATE IMMUNITY; INTESTINE FLORA; MICROBIAL DIVERSITY; MOUSE; MUCOSAL IMMUNITY; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PYROSEQUENCING; SPECIES COMPOSITION;

COLONIC MICROFLORA; CROHN'S DISEASE; INFLAMMATORY BOWEL DISEASE;

ACUTE-PHASE PROTEINS; ANIMALS; BACTERIAL ADHESION; BACTERIAL LOAD; BIOLOGICAL MARKERS; CHRONIC DISEASE; COLITIS; COLON; DNA, BACTERIAL; ENZYME-LINKED IMMUNOSORBENT ASSAY; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTIONS; FECES; FLAGELLIN; GERM-FREE LIFE; IMMUNITY, INNATE; INTESTINAL MUCOSA; LIPOCALINS; LIPOPOLYSACCHARIDES; MICE; MICE, KNOCKOUT; MICROBIOTA; ONCOGENE PROTEINS; SEQUENCE ANALYSIS, DNA; TOLL-LIKE RECEPTOR 5;

EID: 84902281269     PISSN: 00175749     EISSN: 14683288     Source Type: Journal    
DOI: 10.1136/gutjnl-2013-304909     Document Type: Article

References (39)

1. Kaser A, Zeissig S, Blumberg RS. Inflammatory bowel disease. Annu Rev Immunol 2010;28:573-621.
2. Xavier RJ, Podolsky DK. Unravelling the pathogenesis of inflammatory bowel disease. Nature 2007;448:427-34. (Pubitemid 47123518)
3. Chassaing B, Darfeuille-Michaud A. The commensal microbiota and enteropathogens in the pathogenesis of inflammatory bowel diseases. Gastroenterology 2011;140:1720-8.
4. DuPont AW, DuPont HL. The intestinal microbiota and chronic disorders of the gut. Nat Rev Gasto Hepathol 2011;8:523-31.
5. Darfeuille-Michaud A, Boudeau J, Bulois P, et al. High prevalence of adherent-invasive Escherichia coli associated with ileal mucosa in Crohn's disease. Gastroenterology 2004;127:412-21. (Pubitemid 39091889)
6. Martin HM, Campbell BJ, Hart CA, et al. Enhanced Escherichia coli adherence and invasion in Crohn's disease and colon cancer. Gastroenterology 2004;127:80-93. (Pubitemid 38962277)
7. Swidsinski A, Ladhoff A, Pernthaler A, et al. Mucosal flora in inflammatory bowel disease. Gastroenterology 2002;122:44-54. (Pubitemid 34049193)
8. Boudeau J, Glasser AL, Masseret E, et al. Invasive ability of an Escherichia coli strain isolated from the ileal mucosa of a patient with Crohn's disease. Infect Immun 1999;67:4499-509. (Pubitemid 29400425)
9. Duerr RH, Taylor KD, Brant SR, et al. A genome-wide association study identifies IL23R as an inflammatory bowel disease gene. Science 2006;314:1461-3. (Pubitemid 44871953)
10. Hugot JP, Chamaillard M, Zouali H, et al. Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease. Nature 2001;411:599-603. (Pubitemid 32531408)
11. Parkes M, Barrett JC, Prescott NJ, et al. Sequence variants in the autophagy gene IRGM and multiple other replicating loci contribute to Crohn's disease susceptibility. Nat Genet 2007;39:830-2. (Pubitemid 47014496)
12. Wellcome. Genome-wide association study of 14 000 cases of seven common diseases and 3000 shared controls. Nature 2007;447:661-78.
13. Couturier-Maillard A, Secher T, Rehman A, et al. NOD2-mediated dysbiosis predisposes mice to transmissible colitis and colorectal cancer. J Clin Invest 2013;123:700-11.
14. Nenci A, Becker C, Wullaert A, et al. Epithelial NEMO links innate immunity to chronic intestinal inflammation. Nature 2007;446:557-61. (Pubitemid 46514732)
15. Vijay-Kumar M, Sanders CJ, Taylor RT, et al. Deletion of TLR5 results in spontaneous colitis in mice. J Clin Invest 2007;117:3909-21. (Pubitemid 350224100)
16. Zhang L, Danon SJ, Grehan M, et al. Natural colonization with Helicobacter species and the development of inflammatory bowel disease in interleukin-10-deficient mice. Helicobacter 2005;10:223-30. (Pubitemid 40769953)
17. Kullberg MC, Ward JM, Gorelick PL, et al. Helicobacter hepaticus triggers colitis in specific-pathogen-free interleukin-10 (IL-10)-deficient mice through an IL-12- and gamma interferon-dependent mechanism. Infect Immun 1998;66:5157-66. (Pubitemid 29044604)
18. Carvalho FA, Koren O, Goodrich JK, et al. Transient inability to manage proteobacteria promotes chronic gut inflammation in TLR5-deficient mice. Cell Host & Microbes 2012;12:139-52.
19. Vijay-Kumar M, Aitken JD, Carvalho FA, et al. Metabolic syndrome and altered gut microbiota in mice lacking Toll-like receptor 5. Science 2010;328:228-31.
20. Darfeuille-Michaud A, Neut C, Barnich N, et al. Presence of adherent Escherichia coli strains in ileal mucosa of patients with Crohn's disease. Gastroenterology 1998;115:1405-13. (Pubitemid 28545991)
21. Barnich N, Boudeau J, Claret L, et al. Regulatory and functional co-operation of flagella and type 1 pili in adhesive and invasive abilities of AIEC strain LF82 isolated from a patient with Crohn's disease. Mol Microbiol 2003;48:781-94. (Pubitemid 36819062)
22. Chassaing B, Srinivasan G, Delgado MA, et al. Fecal lipocalin 2, a sensitive and broadly dynamic non-invasive biomarker for intestinal inflammation. PLoS One 2012;7:e44328.
23. Hamady M, Walker JJ, Harris JK, et al. Error-correcting barcoded primers for pyrosequencing hundreds of samples in multiplex. Nat Med 2008;5:235-7. (Pubitemid 351325646)
24. Caporaso JG, Kuczynski J, Stombaugh J, et al. QIIME allows analysis of high-throughput community sequencing data. Nat Med 2010;7:335-6.
25. Edgar RC, Haas BJ, Clemente JC, et al. UCHIME improves sensitivity and speed of chimera detection. Bioinformatics 2011;27:2194-200.
26. McDonald D, Price MN, Goodrich J, et al. An improved Greengenes taxonomy with explicit ranks for ecological and evolutionary analyses of bacteria and archaea. ISME J 2012;6:610-18.
27. Caporaso JG, Bittinger K, Bushman FD, et al. PyNAST: a flexible tool for aligning sequences to a template alignment. Bioinformatics 2010;26:266-7.
28. Price MN, Dehal PS, Arkin AP. FastTree: computing large minimum evolution trees with profiles instead of a distance matrix. Mol Biol Evol 2009;26:1641-50.
29. Lozupone C, Knight R. UniFrac: a new phylogenetic method for comparing microbial communities. Appl Environ Microbiol 2005;71:8228-35. (Pubitemid 41803949)
30. Tibshirani R, Hastie T, Narasimhan B, et al. Diagnosis of multiple cancer types by shrunken centroids of gene expression. Proc Natl Acad Sci USA 2002;99:6567-72. (Pubitemid 34526173)
31. Koren O, Spor A, Felin J, et al. Human oral, gut, and plaque microbiota in patients with atherosclerosis. Proc Natl Acad Sci USA 2011;108(Suppl 1):4592-8.
32. Carvalho FA, Nalbantoglu I, Ortega-Fernandez S, et al. Interleukin-1beta (IL-1beta) promotes susceptibility of Toll-like receptor 5 (TLR5) deficient mice to colitis. Gut 2012;61:373-84.
33. Hasegawa M, Osaka T, Tawaratsumida K, et al. Transitions in oral and intestinal microflora composition and innate immune receptor-dependent stimulation during mouse development. Infect Immun 2010;78:639-50.
34. Duck LW, Walter MR, Novak J, et al. Isolation of flagellated bacteria implicated in Crohn's disease. Inflamm Bowel Dis 2007;13:1191-201. (Pubitemid 47597766)
35. Lodes MJ, Cong Y, Elson CO, et al. Bacterial flagellin is a dominant antigen in Crohn disease. J Clin Invest 2004;113:1296-306. (Pubitemid 39069929)
36. Kronman MP, Zaoutis TE, Haynes K, et al. Antibiotic exposure and IBD development among children: a population-based cohort study. Pediatrics 2012;130:e794-803.
37. Barnich N, Carvalho FA, Glasser AL, et al. CEACAM6 acts as a receptor for adherent-invasive E. coli, supporting ileal mucosa colonization in Crohn disease. J Clin Invest 2007;117:1566-74. (Pubitemid 46871341)
38. Carvalho FA, Barnich N, Sivignon A, et al. Crohn's disease adherent-invasive Escherichia coli colonize and induce strong gut inflammation in transgenic mice expressing human CEACAM. J Exp Med 2009;206:2179-89.
39. Ott SJ, Musfeldt M, Wenderoth DF, et al. Reduction in diversity of the colonic mucosa associated bacterial microflora in patients with active inflammatory bowel disease. Gut 2004;53:685-93. (Pubitemid 38561447)